Marina Caskey

Marina Fernandes De Barros Caskey (born 1978, Aracaju, Sergipe)^[1] is a Brazilian^[2] scientist,^[3] immunologist and professor at Rockefeller University.

Marina Caskey
Born	(1978-05-22)22 May 1978 Aracaju-Sergipe=Brazil
Nationality	Brazilian
Academic background
Alma mater	Universidade Federal de Sergipe (MD)
Academic work
Institutions	Rockefeller University

She graduated with a degree in Medicine (MD) from the Federal University of Sergipe.^[4][5] After medical training in Brazil, she did an internal medicine residency at Mount Sinai Morningside (then known at St Luke's), and a fellowship in infectious disease at Cornell's NewYork–Presbyterian Hospital. After her medical training, she did clinical research work on HIV vaccine and vaccine adjuvant development in the lab of Nobel laureate Ralph M. Steinman. Now as a faculty member of Rockefeller, she has led in human clinical trials of neutralizing antibodies against HIV.^[6]

Selected publications

• Caskey, Marina (2020). "Broadly Neutralizing Antihuman Immunodeficiency Virus Antibodies in Infants: Promising New Tools for Prevention of Mother-to-Child Transmission?". The Journal of Infectious Diseases. 222 (4): 525–527. Bibcode:1973PNAS...70.2974C. doi:10.1093/infdis/jiz536. PMC 7377284. PMID 31681956.  

• S. Vasan, S. J. Schlesinger, Z. Chen, A. Hurley, A. Lombardo, S. Than, P. Adesanya, C. Bunce, M. Boaz, R. Boyle, E. Sayeed, L. Clark, D. Dugin, M. Boente-Carrera, C. Schmidt, Q. Fang, L. Ba, Y. Huang, G.J. Zaharatos, D.F. Gardiner, M. Caskey, L. Seamons, M. Ho, L. Dally, C. Smith, J. Cox, D.K. Gill, J. Gilmour, M.C. Keefer, P. Fast, D. D. Ho. Phase 1 Safety and Immunogenicity Evaluation of ADMVA, a Multigenic, Modified Vaccinia Ankara-HIV-1 B./C Candidate Vaccine. PLoS One. 2010 Jan 25;5(1):e8816. PMID 20111599
• Longhi, M.P., Trumpfheller, C., Idoyaga, J., Caskey, M., Matos, I., Kluger, C., Salazar, A.M., Colonna, M., and Steinman, R.M. Dendritic cells require a systemic type 1 interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant. J Exp Med 2009. 206:1589–1602. PMID 19564349
• Trumpfheller C, Caskey M, Nchinda G, Longhi MP, Mizenina O, Huang Y, Schlesinger SJ, Colonna M, Steinman RM. The microbial mimic poly IC induces durable and protective CD4+ T cell immunity together with a dendritic cell targeted vaccine. Proc Natl Acad Sci U S A. 2008 Feb 19;105(7):2574-9. PMID 18256187
• Morgan DJ, Caskey MF, Abbehusen C, Oliveira-Filho J, Araujo C, Porto AF, Santos SB, Orge GO, Joia MJ, Muniz AL, Siqueira I, Glesby MJ, Carvalho E. Brain magnetic resonance imaging white matter lesions are frequent in HTLV-I carriers and do not discriminate from HAM/TSP. AIDS Res Hum Retroviruses. 2007 Dec;23(12):1499-504. PMID 18160007
• Caskey MF; Morgan DJ; Giozza SP; Muniz AL; Carvalho EM; Glesby MJ. Clinical Manifestations of HTLV-I infection: a Case-Control study. AIDS Res Hum Retroviruses. 2007 Mar;23(3):365-71. PMID 17411369

References

1. . Sergipe News (in Portuguese). Archived from the original on 2018-04-14. Retrieved 2018-04-14.
2. G1-Sergipe. "Sergipana está entre cientistas que conseguiram criar anticorpo para HIV". TV Sergipe (in Portuguese).
3. Jornal Nacional. "Cientistas reproduzem anticorpo capaz de neutralizar o HIV". TV Rede Globo de Televisão (in Portuguese).
4. "Marina Caskey, MD – The Rockefeller University » Hospital". The Rockefeller University.
5. Jornal Nacional. . Jornal da Cidade Sergipe (in Portuguese). Archived from the original on 2018-04-14. Retrieved 2018-04-14.
6. "Marina Caskey".